Why Tourism?

Christie, Iain; Fernandes, Eneida Herrera; Messerli, Hannah; Twining-Ward, Louise

doi:10.1596/978-1-4648-0190-7_ch2

Cited by 1 publication

(3 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…7 The number of climbers increased from 22,700 annually during the previous study (1996–2003) 7 to a recently estimated 35,000 to 40,000 annually. 1 The mortality rates are roughly comparable to mortality figures described in the Himalayas for mountains with altitudes of 4000 to 6000 m. 9 Above 6000 m in the Himalayas, mortality increases steeply and is proportionate to increasing altitude.…”

Section: Discussionmentioning

confidence: 54%

“…The ascent by the “tourist route” requires no technical climbing expertise and is attempted by an estimated 35,000 to 40,000 climbers annually. 1 -4 The reported summit success rates vary from 53 to 61% for a 4- to 5-d climb 2,3 to 88% for a 6-d climb. 4 The main limiting factor is high altitude illness (HAI) from rapid ascent.…”

Section: Introductionmentioning

confidence: 98%

“…Each year, over 35 million people visit destinations with altitudes >3000 m above sea level. 1 Mount Kilimanjaro (5895 m) in Tanzania is the highest mountain in Africa. The ascent by the “tourist route” requires no technical climbing expertise and is attempted by an estimated 35,000 to 40,000 climbers annually.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Altitude-Related Disorders on Mount Kilimanjaro, Tanzania: Two-Year Survey in a Local Referral Center

Dekker

Mremi

Kilonzo

et al. 2021

Wilderness & Environmental Medicine

View full text Add to dashboard Cite

Introduction-A significant number of climbers on Mount Kilimanjaro are affected by altituderelated disorders. The aim of this study was to determine the main causes of morbidity and mortality in a representative cohort of climbers based on local hospital records. Methods-We conducted a 2-y retrospective chart review of all patients presenting to the main referral hospital in the region after a climb on Mount Kilimanjaro, including all relevant records and referrals for postmortem studies. Results-We identified 62 climbers who presented to the hospital: 47 inpatients and 15 outpatients. Fifty-six presented with high altitude illness, which included acute mountain sickness (n=8; 14%), high altitude pulmonary edema (HAPE) (n=30; 54%), high altitude cerebral edema (HACE) (n=7; 12%), and combined HAPE/HACE (n=11; 20%). The mean altitude of symptom onset ranged from 4600±750 m for HAPE to 5000±430 m for HAPE/HACE. The vast majority of inpatients (n=41; 87%) were improved on discharge. Twenty-one deceased climbers, most having died while climbing (n=17; 81%), underwent postmortem evaluation. Causes of death were HAPE (n=16; 76%), HAPE/HACE (n=3; 14%), trauma (1), and cardiopulmonary (1). Conclusions-HAPE was the main cause of death during climbing as well as for hospital admissions. The vast majority of climbers who presented to hospital made a full recovery.

show abstract

Section: Discussionmentioning

confidence: 54%